Prof. Dr. Urs A. Meyer
Biozentrum, University of Basel
Curriculum Vitae
| Curriculum Vitae Prof. Dr. med. Urs A. Meyer | |
| Born | Baden, Switzerland |
| Citizenship | Switzerland |
| Address | Biozentrum of the University of Basel Spitalstrasse 41, CH-4056 Basel, Switzerland Phone:+41 61 207 22 20, +41 79 744 7332 E-Mail: urs-a.meyer@unibas.ch Home: Obstgartenstrasse 5, CH-8703 Erlenbach, Switzerland |
Homepage |
http://www.ursmeyer.biozentrum.unibas.ch |
| Educational and Professional Experience | |
| 1958 - 1961 | Basic Medical Sciences, University of Geneva, Switzerland |
| 1964 | Graduation from University of Zürich Medical School |
| 1967 | M.D., Doctoral thesis, University of Zürich, Switzerland |
| 6/65 - 6/67 | Research Assistant, Metabolic Unit, Department of Medicine, University of Zürich Medical School. Work was in the field of adipose tissue metabolism under the direction of E. Rudolf Froesch |
| 7/67 - 6/68 | Internship - Straight Medicine University of California San Francisco Medical Center (UCSF) San Francisco, California. Lloyd H. Smith, Jr., Head of the Department of Medicine. |
| 7/68 - 6/69 | Resident - Internal Medicine University of California Hospitals, San Francisco, California. |
| 9/69 - 9/70 | United States Public Health Service Special Postdoctoral Research Fellowship in Clinical Pharmacology - Department of Medicine University of California San Francisco Medical Center, San Francisco, California. Clinical training in the Division of Clinical Pharmacology under the direction of Kenneth L. Melmon. Research in the field of the relationship between heme turnover and drug metabolism under the direction of Harvey S. Marver and Rudi Schmid. |
| 9/70 - 8/71 | United States Public Health Service Special Postdoctoral Research Fellowship in Hepatology - Departments of Internal Medicine and of Biochemistry, University of Texas Southwestern Medical School, Dallas, Texas, U.S.A., under the direction of Harvey S. Marver and Ronald W. Estabrook. |
| 8/71 - 6/72 | Instructor of Medicine and Pharmacology, Division of Clinical Pharmacology, Department of Medicine, University of California, Medical Center, San Francisco, U.S.A. |
| 7/72 - 6/74 | Assistant Professor of Medicine and Pharmacology. Div. of Clinical Pharma-cology, Dept. of Medicine, University of California, San Francisco, USA. |
| 7/74 - 3/83 | Chief, Division of Clinical Pharmacology, Departments of Medicine and Pharmacology, University of Zürich Medical School, University Hospital, Zürich, Switzerland. |
| 10/76 - 3/83 | Associate Professor of Clinical Pharmacology (Extraordinarius), University of Zürich Medical School, Zürich, Switzerland. |
| 3/83 -7/08 | Professor of Pharmacology (Ordinarius), University of Basel Medical School, and Chairman, Division of Pharmacology/Neurobiology, Biozentrum of the University of Basel, Basel, Switzerland. |
| 7/92 - 6/93 | Visiting Professor, Department of Molecular Pharmacology, Stanford University School of Medicine, Stanford, California, USA |
| 11/93 - 11/95 | Acting Chairman, Biozentrum of the University of Basel, Basel, Switzerland |
| 12/08 - | Professor emeritus of Pharmacology, University of Basel |
| 4/08-7/08 | Sabbatical Professor, Office of Clinical Pharmacology, Center of Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, MD, USA |
| Memberships | |
| The American Society for Pharmacology and Experimental Therapeutics Swiss Society of Clinical Pharmacology and Toxicology (SSCPT), President of the Section Clinical Pharmacology (1986-1988) Drug Metabolism Section, IUPHAR International Society for the Study of Xenobiotics (ISSX) Gesellschaft für Fortschritte in der Inneren Medizin (Ludwig-Heilmeyer-Gesellschaft European Society of Pharmacogenomics and Personalised Therapy (ESPT) The Swiss Group of Pharmacogenomics and Personalised Therapy (SPT) |
|
| Academic Honours | |
| 1971 - 1974 | Faculty Development Award in Clinical Pharmacology, Pharmaceutical Manufacturers Association Foundation |
| 1974 | Cloetta-Award 1974 for Medical Research |
| 1978 | Award of the Anita Saurer Foundation, 1978 |
| 1990 | William D. Stubenboard Visiting Professorships, Cornell Medical Center, New York |
| 1991 | Rawls-Palmer Award for Progress in Medicine (with Frank J. Gonzalez) American Society for Clinicical Pharmacology and Therapeutics |
| 1993 | Featured on Cover Page of Cancer Research for work on Acetyltransferase Genes and Cancer |
| 1993 | The Sterling Drug Visiting Professor, University of Oregon School of Medicine, Portland, Oregon |
| 1993 | Elected Member, Academia Europaea |
| 1994 | The Ariëns Lecture of the Dutch Pharmacological Soc., Leiden |
| 1994 | The Sandoz Lecture in Clinical Pharmacology, USU, Bethesda, MD, USA |
| 1997 | Council, Academia Europaea |
| 1998 | Medeval Distinguished Lecturer, University of Manchester, U.K. |
| 1999 | Werner Kalow Annual Award Lectureship in Pharmacogenetics, Toronto, Canada |
| 2000 | Ad hoc member of the Council of the NIGMS, NIH, Bethesda, USA |
| 2001 | Elected to membership, Swiss Academy of Medical Sciences |
| 2001 | Listed on ISI's Highly Cited Researcher's database |
| 2002 | External Scientific Panel-NIH Pharmacogenetics Research Network |
| 2003 | Vice-President, Academia Europaea |
| 2004 | Robert Pfleger-Forschungspreis 2004 |
| 2004 | RT Williams Distinguished Scientific Achievement Award” International Society for the Study of Xenobiotics” ISSX in Bethesda, MD, USA |
| Activities | |
| 1981 - 1991 | National Research Council, Swiss National Science Foundation |
| 1988 - 1992 | Advisory Board, Robert Bosch Stiftung, Stuttgart, Germany |
| 1989 - 1991 | President, Clinical Section, Division of Biology and Medicine, Swiss National Science Foundation |
| 1989 - 1996 | Member of the Board of Trustees, Sandoz Foundation for Gerontological Research, Basel. |
| 1994 - 1998 | Scientific Council, International Agency for Research on Cancer (IARC), WHO, Lyon, France |
| 1997 - 2000 | Swiss Board of Consultants, Basel Institute for Immunology |
| 2000 - | Co-editor Pharmacogenomics, Faculty 1000 |
| 2010 - 2011 | President, International Society for the Study of Xenobiotics |
| 2012 - 2015 | President, European Center for Pharmaceutical Medicine Foundation |
| Editorial boards | |
| Editor | Associate Editor, Annual Reviews of Pharmacology and Toxicology (2015-2023 ) Editor-in-Chief, Journal of Personalized Medicine ( 2011- 2014) Co-Editor “pharma-kritik” Co-Editor, Progress in Drug Research (1986 - 1988) Co-Editor, Advances in Drug Research (1993 - 1997) |
| Editorial boards | European Journal of Clinical Pharmacology (1985 - 2000) Clinical Pharmacology and Therapeutics (1986 - 1998) Thérapie (1990 - ) Hepatology (1991 - 1997) Journal of Molecular Medicine (1994 - 2002) Pharmacogenetics & Genomics (1991 - ) Molecular Diagnosis & Therapy (2000 - ) Annual Review of Pharmacology & Toxicology (2005 -) Drug Metabolism and Drug Interactions , now Drug Metabolism and Personalized Therapy (2010 - ) |
| Publications | > 350; h-index 97, > 34’000 citations (Google Scholar 2023) |
| Patents | 1) US Patent 07/845, 507 (Coinventor) "Method for identifying humans with genetic defects in drug metabolism" 2) US Patent Nr. 5,648,482 "Primers targeted to CYP2D6 gene for detecting poor metabolizers of drugs". |
| License agreement | BD-Biosciences, Woburn, USA |
| Other activities | Scientific advisor for various biotech and pharma companies. Board of Directors, PharmaSens AG |
Research
Personal
Media
